{
    "ticker": "OTSKY",
    "name": "Otsuka Pharmaceutical Co., Ltd.",
    "description": "Otsuka Pharmaceutical Co., Ltd. is a global healthcare company focused on the research, development, and commercialization of innovative pharmaceuticals and nutraceuticals. Founded in 1964 and headquartered in Tokyo, Japan, Otsuka operates in various therapeutic areas, including psychiatry, neurology, and oncology, with a commitment to addressing unmet medical needs. The company is known for its flagship product Abilify (aripiprazole), an antipsychotic medication widely used for the treatment of schizophrenia and bipolar disorder. Otsuka also emphasizes the importance of mental health and has developed a range of products that cater to patients with mental health disorders. In addition to pharmaceuticals, Otsuka produces a variety of consumer products, including functional foods and beverages, which support health and wellness. The company is dedicated to innovation and invests heavily in research and development, collaborating with academic institutions and other organizations to advance healthcare solutions. Otsuka's mission is to contribute to the health of people worldwide by leveraging its diverse portfolio and commitment to quality, safety, and efficacy in all its products.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Tokyo, Japan",
    "founded": "1964",
    "website": "https://www.otsuka.co.jp/en/",
    "ceo": "Taro Iwamoto",
    "social_media": {
        "twitter": "https://twitter.com/otsukapharma",
        "linkedin": "https://www.linkedin.com/company/otsuka-pharmaceutical-co-ltd/"
    },
    "investor_relations": "https://www.otsuka.com/en/investors/",
    "key_executives": [
        {
            "name": "Taro Iwamoto",
            "position": "CEO"
        },
        {
            "name": "Toshio Sato",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Abilify",
                "Rexulti",
                "Samsca"
            ]
        },
        {
            "category": "Nutraceuticals",
            "products": [
                "Pocari Sweat",
                "Soyjoy"
            ]
        }
    ],
    "seo": {
        "meta_title": "Otsuka Pharmaceutical Co., Ltd. | Innovative Pharmaceuticals and Nutraceuticals",
        "meta_description": "Explore Otsuka Pharmaceutical Co., Ltd., a leader in innovative healthcare solutions focusing on mental health and wellness. Discover the company's commitment to improving global health.",
        "keywords": [
            "Otsuka Pharmaceutical",
            "Mental Health",
            "Pharmaceuticals",
            "Nutraceuticals",
            "Abilify",
            "Innovative Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What is Otsuka Pharmaceutical known for?",
            "answer": "Otsuka Pharmaceutical is known for its innovative pharmaceuticals, particularly in psychiatry and neurology, as well as its nutraceutical products."
        },
        {
            "question": "Who is the CEO of Otsuka Pharmaceutical?",
            "answer": "Taro Iwamoto is the CEO of Otsuka Pharmaceutical Co., Ltd."
        },
        {
            "question": "Where is Otsuka Pharmaceutical headquartered?",
            "answer": "Otsuka Pharmaceutical is headquartered in Tokyo, Japan."
        },
        {
            "question": "What are Otsuka's main products?",
            "answer": "Otsuka's main products include Abilify, Rexulti, and various nutraceuticals like Pocari Sweat."
        },
        {
            "question": "When was Otsuka Pharmaceutical founded?",
            "answer": "Otsuka Pharmaceutical was founded in 1964."
        }
    ],
    "competitors": [
        "JNJ",
        "PFE",
        "MRK",
        "BMY"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "NOVN"
    ]
}